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Background: In moderate acute respiratory distress syndrome (ARDS) several studies support the usage of assisted
spontaneous breathing modes. Only limited data, however, focus on the application in systemic sepsis and
developing lung injury. The present study examines the effects of immediate initiation of pressure support
ventilation (PSV) in a model of sepsis-induced ARDS.
Methods: 18 anesthetized pigs received a two-staged continuous lipopolysaccharide infusion to induce lung injury.
The animals were randomly assigned to PSV or volume controlled (VCV) lung protective ventilation (tidal volume
each 6 ml kg-1, n = 2x9) over six hours. Gas exchange parameters, hemodynamics, systemic inflammation, and
ventilation distribution by multiple inert gas elimination and electrical impedance tomography were assessed.
The post mortem analysis included histopathological scoring, wet to dry ratio, and alveolar protein content.
Results: Within six hours both groups developed a mild to moderate ARDS with comparable systemic
inflammatory response and without signs of improving gas exchange parameters during PSV. The PSV group
showed signs of more homogenous ventilation distribution by electrical impedance tomography, but only slightly
less hyperinflated lung compartments by multiple inert gas elimination. Post mortem and histopathological
assessment yielded no significant intergroup differences.
Conclusions: In a porcine model of sepsis-induced mild ARDS immediate PSV was not superior to VCV. This
contrasts with several experimental studies from non-septic mild to moderate ARDS. The present study therefore
assumes that not only severity, but also etiology of lung injury considerably influences the response to early
initiation of PSV.
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In the course of non-pulmonary sepsis respiratory failure
is a common cause and occurs in about 50% of the
patients with severe sepsis [1]. Patients suffering from
sepsis often require mechanical ventilation, even if they
do not fulfill the criteria of an acute respiratory distress
syndrome (ARDS). On the other hand, mechanical venti-
lation itself can represent the second hit leading to the
development of ARDS. Independent from the underlying* Correspondence: alexander.ziebart@unimedizin-mainz.de
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unless otherwise stated.illness, lung protective strategies that aim to minimize
ongoing pulmonary damage by targeting low tidal
volumes and limitation of the inspiratory pressure are
regarded as the key interventions when the criteria of
ARDS are met [2,3]. In severe ARDS there is evidence
that short-term neuromuscular blockade enables the
consequent realization of low tidal volume ventilation
and increases survival rates [4]. In mild to moderate or
post-acute ARDS, however, the admittance of spon-
taneous breathing is reported to improve gas exchange,
reduce diaphragmatic dysfunction and enable a faster
weaning [5,6]. Several experimental models report bene-
ficial effects of spontaneous breathing in various patternsLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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[7-9]. These findings, though, have not been verified in
primary sepsis-related lung injury. Furthermore, some
clinical and experimental data also suggest the value of
preventive initiation of lung protective ventilation [10].
But currently the appropriate guidelines do not state
on the preemptive application of lung protective venti-
lation or spontaneous breathing in early sepsis-
induced lung injury [11].
We hypothesized that in early sepsis immediate appli-
cation of pressure support ventilation (PSV) targeted to
a tidal volume (Vt) of 6 ml kg
-1 will improve the pul-
monary function in comparison to conventional volume
controlled ventilation (VCV, Vt 6 ml kg
-1). Hence, we
compared the early effects of PSV and VCV on gas ex-
change, ventilation/perfusion distribution and histo-
pathological lung injury in a porcine model of systemic,
lipopolysaccharide (LPS)-induced sepsis subsequently
leading to lung injury.Methods
The study was approved by the State and Institutional
Animal Care Committee (Landesuntersuchungsamt
Rheinland-Pfalz, Koblenz, Germany; approval number:
G10-1-004). 18 juvenile pigs (Sus scrofa domestica,
weight 27 ± 2 kg) were examined in a prospective-
randomized setting.Anesthesia and instrumentation
The animals were sedated by an intramuscular in-
jection of ketamine (8 mg kg.1) and midazolam
(0.2 mg kg-1). Anesthesia was induced by intravenous
application of propofol (4 mg kg-1) and fentanyl
(4 μg kg-1). A single shot of atracurium (0.5 mg kg-1)
was added to facilitate endotracheal intubation (in-
ternal diameter 7.5 mm tube). General anesthesia was
maintained by infusion of ketamine (10-20 mg kg-1 h-1)
and midazolam (0.5-2 mg kg-1 h-1). Volume controlled
ventilation (VCV; AVEA, CareFusion, USA) was used
during the preparation period: Vt 6 ml kg
-1, positive
end-expiratory pressure (PEEP) 7 cmH2O, fraction of
inspired oxygen (FiO2) 0.35, variable respiratory rate
to guarantee an endtidal CO2 (etCO2) < 8 kPa, and
ph >7.2. Vascular catheters were placed ultrasound-
guided in Seldinger’s technique by femoral access: a
central venous line, a pulmonary arterial catheter and a
PiCCO®-System (Pulsion Medical Systems, Germany).
Spirometry and hemodynamics were permanently
stored (Datex S/5, GE Healthcare, Germany). The
esophageal pressure was measured with an esophageal
balloon catheter. Body temperature was measured by a
rectal probe, while a surface-warming device main-
tained normothermia.Experimental protocol
Figure 1 summarizes the experimental protocol. Septic
inflammatory response was induced by continuous LPS
infusion (E. coli Serotype O111:B4, Sigma-Aldrich,
Switzerland). The infusion scheme includes a high-dose
induction (100 μg kg-1 h-1) over one hour and a main-
tenance dosage (10 μg kg-1 h-1) for the entire experi-
ment. Following anesthesia and preparation, but before
sepsis induction a non-participant randomized the ani-
mals by drawing one of 18 envelopes containing the re-
spective ventilation mode:
PSV-Mode (n = 9): pressure support 15 ± 5 cmH2O, Vt
6 ml kg-1, PEEP 5 cmH2O, FiO2 0.35, trigger =
1.5 l min-1 targeted to an etCO2 < 8 kPa and ph > 7.2
VCV-Mode (n = 9): Vt 6 ml kg
-1, PEEP 5 cmH2O, FiO2
0.35, variable respiratory rate targeted to an etCO2 < 8
kPa and ph > 7.2
The VCV group received repeated injections of atra-
curium (0.5 mg kg-1) to avoid the onset of spontaneous
breathing under close monitoring of depth of anesthesia.
Measurements were performed at baseline, three and six
hours after sepsis induction. To prevent severe hypox-
emia or hypercapnia during LPS infusion and developing
lung injury that would lead to implausible results, we
established an intervention scheme instead of using a
fixed setting, which was oriented on the ARDS Net-
work PEEP/FiO2 tables: if the peripheral oxygen saturation
dropped under 92% for five minutes, the ventilation pa-
rameters were adapted. During the experiment a balanced
saline solution (5 ml kg-1 h-1; Sterofundin, B. Braun
Germany) was applied continuously. In case of hemo-
dynamic instability (mean arterial pressure < 60 mmHg)
the animals received a hydroxylethyl starch infusion
(90 ml h-1; Volulyte 6%, Fresenius Kabi, Germany) and
an additional bolus once per hour. Persisting instability
was treated by continuous noradrenaline infusion. The
animals were monitored over six hours following sepsis
induction. At the end of the experiments the animals
were killed in deep general anesthesia by intravenous in-
jection of propofol (200 mg) and exsanguination.Electrical impedance tomography and multiple inert gas
elimination technique
A 16-electrode electrical impedance tomography device
(EIT; Goe-MF II, CareFusion, Germany) recorded rela-
tive bioimpedance changes related to pulmonary aer-
ation. To analyze the regional ventilation distribution,
the percentage of the respiratory-dependent relative im-
pedance changes was attributed to three regions of inter-
est (non-dependent, central, dependent). Setup, data
acquisition and processing were previously described in
Figure 1 Experimental protocol. EIT: electrical impedance tomography, MIGET: multiple inert gas elimination technique.
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tion was assessed by means of micropore membrane inlet
mass spectrometry - multiple inert gas elimination tech-
nique (MMIMS-MIGET, Oscillogy LLC, USA) [14,15].
Post mortem and histopathological analysis
The lungs were extracted en bloc under continuous
positive airway pressure. The upper left lobe was used
for bronchoalveolar lavage to determine the alveolar
protein content. The lower left lobe was weighted andTable 1 Respiratory and haemodynamic data
Variables
VCV
Baseline 3 h 6 h
FiO2 [%] 36 ± 1 47 ± 13 56 ± 18
Ppeak [cm H2O] 17 ± 2 23 ± 5 26 ± 6
Pmean [cm H2O] 9 ± 1 13 ± 3 15 ± 5
PEEP [cmH2O] 7 ± 1 10 ± 4 12 ± 5
ΔPes [cm H2O] 0 ± 0 0 ± 2 0 ± 1
Ptp [cm H2O] 7 ± 2 6 ± 1 6 ± 1
Vt [ml kg
-1] 6.8 ± 2.1 5.3 ± 2.0 5.5 ± 2.1
RR [min-1] 36 ± 8 45 ± 5 46 ± 5
Cdyn [ml cm H2O
-1] 32 ± 11 14 ± 8 14 ± 6
pH 7.38 ± 0.04 7.17 ± 0.09 7.25 ± 0.08
AaDO2 [mmHg] 42 ± 19 174 ± 86 229 ± 138
etCO2 [kPa] 5.5 ± 0.4 5.5 ± 0.5 4.7 ± 0.6
HR [min-1] 106 ± 20 141 ± 27 127 ± 25
MAP [mmHg] 96 ± 6 68 ± 11 73 ± 13
MPAP [mmHg] 26 ± 6 46 ± 5 38 ± 5
CVP [mmHg] 14 ± 3 14 ± 3 15 ± 1
CO [L min-1] 4.2 ± 0.7 3.1 ± 0.6 2.6 ± 0.6
SVR [dyn s cm-5] 1570 ± 313 1493 ± 484 1916 ± 417
NA [μg kg-1 min-1] 0 ± 0 0.2 ± 0.3 0.3 ± 0.3
Data are reported as mean ± SD. Group effects over time are analyzed by two-way-
baseline. n.s. = non-significant.
FiO2: fraction of inspired oxygen; Ppeak: peak inspiratory pressure; Pmean: mean airwa
esophageal pressure; Ptp: transpulmonary pressure; Vt: tidal volume; RR: respiratory
etCO2: endtidal carbon dioxide; HR: heart rate; MAP: mean arterial pressure; MPAP:
output; SVR: systemic vascular resistance; NA: noradrenaline dosage.dried to measure the wet to dry ratio. The right lung
was used to quantify the histopathological damage ori-
ented on established scoring systems [16]. The assess-
ment was performed in investigator-blinded manner
under supervision of an experienced pathologist.
Representative samples of different regions (non-
dependent, central, dependent) were extracted and fixed
in formalin for paraffin sectioning and hematoxylin/eosin
staining. The evaluation included seven different parame-
ters: overdistension, epithelial destruction, inflammatoryPSV Group
effectBaseline 3 h 6 h
36 ± 1 43 ± 11 52 ± 25 n.s.
16 ± 2 20 ± 4 25 ± 9 n.s.
9 ± 1 10 ± 3 13 ± 6 n.s.
7 ± 1 5 ± 2 9 ± 5 n.s.
0 ± 0 0 ± 1 0 ± 1 n.s.
6 ± 1 7 ± 1 7 ± 1 n.s.
6.2 ± 0.5 6.5 ± 0.6 7.1 ± 1.2 n.s.
39 ± 5 39 ± 15 37 ± 10 p = 0.04
33 ± 14 14 ± 4 13 ± 4 n.s.
7.34 ± 0.06 7.21 ± 0.04 7.19 ± 0.11 n.s.
48 ± 26 167 ± 90 214 ± 158 n.s.
5.3 ± 0.3 6.2 ± 1.1 7.8 ± 4.5 p = 0.02
103 ± 24 132 ± 22 127 ± 25 n.s.
90 ± 10 66 ± 7 72 ± 14 n.s.
26 ± 4 43 ± 7 35 ± 10 n.s.
14 ± 1 13 ± 1 14 ± 2 n.s.
4.2 ± 1.3 3.3 ± 0.8 3.2 ± 0.7 n.s.
1547 ± 405 1402 ± 397 1427 ± 185 n.s.
0 ± 0 0.1 ± 0.2 0.2 ± 0.3 n.s.
ANOVA and with Holm-Sidak procedure. No intergroup differences during
y pressure; PEEP: positive end-expiratory pressure, ΔPes: difference of the
rate; Cdyn: dynamic lung compliance; AaDO2: alveolar-arterial oxygen difference;
mean pulmonary arterial pressure; CVP: central venous pressure; CO: cardiac
Figure 2 Quotient of PaO2 and FiO2 (PaO2/FiO2). Group effects
over time are analyzed by two-way-ANOVA and post-hoc Holm-Sidak
procedure. n.s. = non-significant, PSV: pressure support ventilation, VCV:
volume-controlled ventilation.
Ziebart et al. Respiratory Research 2014, 15:101 Page 4 of 9
http://respiratory-research.com/content/15/1/101infiltration, alveolar edema, hemorrhage, interstitial
edema, and microatelectasis. Per region each param-
eter received a severity grade from zero to five points
in four non-overlapping fields of view. In a second step
the extent of each parameter was assessed in a global
overview of the entire region. This results in a summa-
rized score of 175 maximum points per region. Plasma
levels of inflammatory cytokines (IL-6, TNF-α) were
determined by means of enzyme-linked immunosorbent
assays (Porcine IL-6 Quantikine ELISA; Porcine TNF-Figure 3 Regional distribution of the tidal volume [% of the global tid
*indicates p < 0.05 during Baseline. Group effects over time are analyzed by
support ventilation, VCV: volume-controlled ventilation, L1-L3: Level 1-3.alpha Quantikine ELISA, R&D System, Germany). Lactate,
thrombocytes and leukocytes were analyzed by the Insti-
tute of Laboratory Medicine, University Medical Centre
Mainz.
Statistical analysis
Data are reported as mean and standard deviation (SD)
or box-plots. Baseline values were compared by t-test or
Mann-Whitney-U-Test depending on presence of Gauss-
ian distribution. The effects of group (PSV vs. VCV) and
group over time were assessed by two-way analysis of vari-
ance (ANOVA) and post-hoc Holm-Sidak-Test. Post mor-
tem data were examined by Mann-Whitney-U-Test and
adjusted for multiple comparisons by the Bonferroni
method. P values < 0.05 are regarded as significantly differ-
ent. The statistical software SigmaPlot 12.5 (Systat Soft-
ware, Germany) was used.
Results
The study protocol was completed in all 18 animals.
Table 1 summarizes the ventilatory and hemodynamic
data and shows no intergroup differences at baseline.
Gas exchange and respiratory variables
After sepsis induction both groups developed a ratio of
the arterial partial pressure of oxygen (PaO2) and FiO2
lower than 300 mmHg (Figure 2). Despite higher PaO2/
FiO2 during PSV the values did not reach significance.
Tolerable hypercapnia occurred in both groups, which
was more pronounced during PSV (p = 0.02) and caused
by lower breathing frequencies (p = 0.04). Ventilatory
pressures and FiO2 had to be raised over time andal amplitude] measured by electrical impedance tomography.
two-way-ANOVA and post-hoc Holm-Sidak procedure. PSV: pressure
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group-related differences.
Regional ventilation distribution and VA/Q ratios
Regional ventilation distribution and VA/Q were assessed
by EIT respectively MMIMS-MIGET at baseline, three and
six hours. Starting during baseline the EIT data (Figure 3)
show a more homogenous distribution of tidal ventilation
between the central and non-dependent lung compart-
ments in the PSV group. The regional ventilation in the
central compartment is significantly higher in the VCV-
group and correspondingly lower in the dependent area.
The VA/Q analysis approves healthy baseline conditions.
During sepsis increasing shunt and hypoventilated lung
areas (low VA/Q) represent the main mode of gas exchange
impairment (Figure 4). In the early course (hours 1-3) the
VCV group tends to develop higher amounts of shunt and
low VA/Q ratios. After six hours measureable, but still non-
significant high VA/Q ratios indicating hyperinflation de-
velop in the VCV group.Figure 4 Ventilation/Perfusion Distribution (VA/Q) measured by MMIM
low VA/Q (0.005 < VA/Q < 0.1), normal VA/Q (0.1 < VA/Q < 10), high VA/Q (10
ANOVA and post-hoc Holm-Sidak procedure. n.s. = non-significant, PSV: preHemodynamics and systemic inflammation
Hypotension, decreased cardiac output, and increased
pulmonary arterial pressure required noradrenaline in-
fusion to maintain stable conditions without diffe-
rences between PSV and VCV. Additionally, both
groups received hydroxylethyl starch administration of
389 ± 261 ml (PSV) and 458 ± 428 ml (VCV; p = 0.86).
Due to high variances the two groups differ in leuco-
cyte levels during baseline. In both groups the systemic
LPS exposition resulted in increasing lactate levels and
leucopenia. Peak cytokine levels developed within
three hours following the initial high-dose LPS admin-
istration and persisted at increased levels over six
hours (Figure 5).
Post mortem analysis
The histopathological analysis approves the presence of
sustained lung injury in both groups without intergroup
differences or regional variances (Figure 6). In the pooled
data from both groups, however, the extent of lung injuryS-MIGET. VA/Q ratios were defined as follows: shunt (VA/Q < 0.005),
< VA/Q > 100). Group effects over time are analyzed by two-way-
ssure support ventilation, VCV: volume-controlled ventilation.
Figure 5 Hematologic parameters associated with the systemic inflammatory response to LPS administration. Group effects over time
are analyzed by two-way-ANOVA and post-hoc Holm-Sidak procedure. n.s. = non-significant, PSV: pressure support ventilation, VCV:
volume-controlled ventilation.
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dependent region). The alveolar protein content and
pulmonary wet/dry ratio did not differ between the
two groups (Figure 6; p = 0.98 respectively p = 0.67).
Discussion
The present study features the following main findings:
in a porcine model of exclusively sepsis-related lung
injury the immediate initiation of low Vt-PSV was fea-
sible, but not superior to low Vt-VCV in terms of gas
exchange, respiratory pattern, hemodynamic stability, and
did not improve histopathological parameters over six
hours.
Sepsis is one of the most frequent risk constellations
of ARDS. Systemic LPS exposition triggers inflammation
by releasing pro-inflammatory cytokines and leucocyte ac-
cumulation. The early response in experimental models is
characterized by acute leucopenia and immense cytokine
levels. Hemodynamic findings include decreased systemic
blood pressure and pulmonary arterial hypertension[17,18]. Our model adequately reproduces these com-
mon early findings. Following central venous LPS infu-
sion the lungs are the first microcirculatory bed to
pass. Nevertheless, short-term LPS exposition hardly
leads to immediate or persisting ARDS [19,20]. On the
other hand, occurrence of severe hemodynamic failure
or septic shock conditions limits the systemic LPS
application in experimental models. We therefore chose a
two-staged infusion regime that caused significant gas
exchange deterioration. The reduced maintenance dosage
of LPS may also account for a clinically relevant reduction
of bacteremia due to therapy. In contrast, primary pul-
monary models like bronchoalveolar lavage or acid aspi-
ration rapidly generate atelectasis, reduced lung compliance
and gas exchange impairment directly from the begin-
ning on.
The admittance of assisted spontaneous breathing ac-
tivity can improve the pulmonary function in compari-
son to conventional lung protective ventilation [6].
Beneficial effects of PSV from several experimental
Figure 6 Post-mortem assessment: histopathological lung injury score (LIS) in different lung regions (A-C) and overall score that
represents the mean value of the three region (D), protein content in the bronchoalveolar lavage fluid (E) and pulmonary wet/dry
ratio (F). No significant intergroup differences.
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blood flow redistribution and overall gas exchange, as
well as attenuation of lung injury and IL-6 levels [8,21].
Sophisticated variable pressure support ventilation has
shown the potential to further increase these effects in
several experimental studies [7,8,22] and is currently
tested for clinical application [23,24]. The early use of
PSV can decrease sedation requirements, improve the
cardiopulmonary function and VA/Q matching. The
number of days under mechanical ventilation on can
also be reduced [25-28]. However, more severely lung
injured patients tend to respond poorly to PSV [29].
Additionally, it is reported that early PSV increases
patient–ventilator asynchrony [6,30]. This effect may
lead to high and harmful tidal volumes even in the early
phase of ventilation [31].
Our present findings do not reproduce a significant
improvement of gas exchange or lung injury. Ventilation
was more homogenously distributed between the central
and non-dependent compartment during PSV, but
merely a non-significant amount of high VA/Q compart-
ments indicating hyperinflation developed in the VCVgroup. This is a considerable contrast to the upper
mentioned results. However, it is worth to take model
dependent characteristics into account: for most experi-
mental studies focusing on various assisted spontaneous
breathing modes the bronchoalveolar lavage/surfactant-
depletion model was used. Furthermore, the assumed
mechanisms that mitigate lung injury through sponta-
neous ventilation vary between several studies and are
not fully elucidated [6]. The lavage model immediately
induces atelectasis due to surfactant depletion, which are
relative easy to recruit in the early phase [29], whereas
LPS-injured lungs tend to respond poorly to recruitment
strategies [32]. In a rabbit model of lavage-induced lung
injury PSV was beneficial only in mild ARDS, though ag-
gravated a pre-existing severe lung injury [33]. The
present data, in this context, assume that not only the
severity but also etiology and pathophysiologic conside-
rations may considerably influence the response to early
PSV. Furthermore, PSV was started before outright
fulfillment of ARDS criteria in our model.
Endotoxemia alone causes a relatively moderate VA/Q
impairment in the short run [34]. This is reflected in the
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ous data from a porcine sepsis model combined with
non-protective ventilation reported a shunt fraction of
17.3 ± 7.5 [34] without occurrence of low VA/Q units,
whereas low VA/Q units represent the predominant pat-
tern of impairment during our low Vt modes (Figure 5).
Furthermore, LPS but not bronchoalveolar lavage com-
promises the hypoxic pulmonary vasoconstriction [35],
which should partially compensate the gas exchange def-
icit. Supporting our results, LPS administration did not
significantly affect the ventilation distribution, but only
influenced the perfusion pattern [36].
The present study has some limitations: the group
sizes were adapted to previous publications that
showed beneficial effects of PSV in early ARDS without
a prior power analysis. Due absence of a clear-cut
trend, however, it appears unlikely that the lack of
effect is essentially influenced by the group sizes. We
applied standard PSV and not promising but sophisti-
cated spontaneous ventilation approaches like variable,
proportional or neutrally adjusted ventilation [6,37].
However, the initiation of early PSV in beginning sepsis
should be feasible almost anywhere, not just in specia-
lized intensive care units. Several studies showed that
spontaneous ventilation attenuates histopathological
lung injury in mild to moderate ARDS models [7,8,33].
But inflammatory response was only slightly altered in
comparison to conventional lung protective ventilation
[8], while gene expression analysis yielded no signifi-
cant differences in pulmonary mRNA expression of
inflammatory marker genes [7]. With regard to the re-
ported model characteristics and ongoing LPS expo-
sition, which is documented in the high plasma
cytokine levels (Figure 3), significant variances in tis-
sue contents of inflammatory markers are highly im-
probable without the presence of an anti-inflammatory
agent over six hours. The present study was designed
to focus the early phase of sepsis with a developing
lung injury. If possible effects over six hours proceed
towards improved long-term outcome, is merely
speculative. Nevertheless, adequate identification and
selection of patients may considerably influence the
effectiveness of early PSV.
Conclusion
In a porcine model of early LPS-induced lung injury di-
rect initiation of low Vt-PSV did not improve pulmonary
function or affect lung injury in comparison to low Vt-
VCV within six hours. This is a contrast to several stu-
dies that report beneficial effects of assisted spontaneous
breathing modes in non-septic experimental models of
mild to moderate ARDS. Early response to PSV in ARDS
seems to be determined not exclusively by severity but
also by etiology of the developing lung injury.Abbreviations
ANOVA: Analysis of variance; ARDS: Acute respiratory distress syndrome;
EIT: Electrical impedance tomography; etCO2: Endtidal CO2; FiO2: Fraction
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MIGET: Micropore membrane inlet mass spectrometry - multiple inert gas
elimination technique; PaO2: Arterial partial pressure of oxygen; PSV: Pressure
support ventilation; PEEP: Positive end-expiratory pressure; Vt: Tidal volume;
VA/Q: Ventilation/perfusion distribution; VCV: Volume controlled ventilation.
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